Article Details
Retrieved on: 2024-10-01 15:30:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Sana Biotechnology, Inc. (NASDAQ:SANA), a clinical-stage biotechnology company, stands at a critical juncture as it navigates through a series of ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here